Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
228 * !
|
Mon, 7/30/2018,
2:00 PM -
3:50 PM
|
CC-West 215/216
|
|
Innovative Statistical Designs with Real Life Case Studies for New Paradigms in Oncology Drug Development — Topic Contributed Papers
|
|
Biopharmaceutical Section, Society for Clinical Trials, ENAR
|
|
Organizer(s): Xiaoyun (Nicole) Li, Merck
|
|
Chair(s): Robert Beckman, Georgetown University
|
|
2:05 PM
|
An Application of 2-In-1 Adaptive Phase 2/3 Design for Expedited Oncology Drug Development
Xinqun (Maggie) Chen, Merck & Co., Inc.; Linda Sun, Merck & Co., Inc.; Cong Chen, Merck & Co.
|
|
2:25 PM
|
A Generalized Design for a Confirmatory Basket Trial
Robert Beckman, Georgetown University; Xiaoyun (Nicole) Li, Merck
|
|
2:45 PM
|
GBM AGILE: a Phase II/III Platform Design with Signature Identification
Todd Graves, Berry Consultants LLC; Donald A Berry, Berry Consultants and M.D. Anderson Cancer Center; Jason Connor, ConfluenceStat LLC
|
|
3:05 PM
|
A Parametric Multiple Comparison Procedure for Clinical Trials with Planned Evaluation of Treatment Effect in Pre-Defined Subgroups and Interim Analyzes
Liang Fang, MyoKardia; Ron Yu, Gilead Sciences, Inc.; Zhishen Ye, Gilead Sciences; Neby Bekele, Gilead Sciences; Ming Lin, Gilead Sciences
|
|
3:25 PM
|
Discussant: Yu Ding, Merck
|
|
3:45 PM
|
Floor Discussion
|
|
